Cargando…

Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting 1% of the world population. RA is associated with the presence of autoantibodies, of which anti-citrullinated protein antibodies (ACPA) are most prominent. ACPA are produced by citrullinated antigen-binding B cells that have presuma...

Descripción completa

Detalles Bibliográficos
Autores principales: Slot, Linda M., Vergroesen, Rochelle D., Kerkman, Priscilla F., Staudinger, Ellen, Reijm, Sanne, van Dooren, Hugo J., van der Voort, Ellen I. H., Huizinga, Tom W. J., Toes, René E. M., Scherer, Hans U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009422/
https://www.ncbi.nlm.nih.gov/pubmed/33784344
http://dx.doi.org/10.1371/journal.pone.0247847
_version_ 1783672872731934720
author Slot, Linda M.
Vergroesen, Rochelle D.
Kerkman, Priscilla F.
Staudinger, Ellen
Reijm, Sanne
van Dooren, Hugo J.
van der Voort, Ellen I. H.
Huizinga, Tom W. J.
Toes, René E. M.
Scherer, Hans U.
author_facet Slot, Linda M.
Vergroesen, Rochelle D.
Kerkman, Priscilla F.
Staudinger, Ellen
Reijm, Sanne
van Dooren, Hugo J.
van der Voort, Ellen I. H.
Huizinga, Tom W. J.
Toes, René E. M.
Scherer, Hans U.
author_sort Slot, Linda M.
collection PubMed
description Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting 1% of the world population. RA is associated with the presence of autoantibodies, of which anti-citrullinated protein antibodies (ACPA) are most prominent. ACPA are produced by citrullinated antigen-binding B cells that have presumably survived tolerance checkpoints. So far, it is unclear how and when such autoreactive B cells emerge. Light chain (LC) rearrangement and mutation rates can be informative with regard to selection steps during B-cell development. Therefore, we studied LC characteristics of ACPA-expressing B cells and secreted ACPA with the aim to better understand the development of this disease-specific, autoreactive B-cell response. Paired ACPA-IgG and ACPA-depleted IgG were isolated from serum (n = 87) and synovial fluid (SF, n = 21) of patients with established RA. We determined the LC composition for each fraction by ELISA using kappa(Igκ)- and lambda(Igλ) LC-specific antibodies. Cellular LC expression was determined using flow cytometry. In addition, we used a B-cell receptor (BCR)-specific PCR to obtain LC variable region sequences of citrullinated antigen- and tetanus toxoid (TT)-binding B cells. In serum, we observed an increased frequency of lambda LC in ACPA-IgG (1.64:1) compared to control IgG (2.03:1) and to the κ/λ ratio reported for healthy individuals (2:1). A similar trend towards higher frequencies of lambda LCs was observed for ACPA-IgG in SF (1.84:1). Additionally, the percentage of Igλ-expressing B cells was higher for citrullinated antigen-binding B cells (51%) compared to TT-specific (43%) and total CD19(+)CD20(+) B cells (36%). Moreover, an increased Igλ percentage was observed in BCR-sequences derived from ACPA-expressing (49%) compared to TT-specific B cells (34%). Taken together, we report an enhanced frequency of lambda LCs in the secreted ACPA-IgG repertoire and, on the cellular level, in BCR sequences of ACPA-expressing B cells compared to control. This skewing in the autoreactive B-cell repertoire could reflect a process of active selection.
format Online
Article
Text
id pubmed-8009422
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-80094222021-04-07 Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis Slot, Linda M. Vergroesen, Rochelle D. Kerkman, Priscilla F. Staudinger, Ellen Reijm, Sanne van Dooren, Hugo J. van der Voort, Ellen I. H. Huizinga, Tom W. J. Toes, René E. M. Scherer, Hans U. PLoS One Research Article Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting 1% of the world population. RA is associated with the presence of autoantibodies, of which anti-citrullinated protein antibodies (ACPA) are most prominent. ACPA are produced by citrullinated antigen-binding B cells that have presumably survived tolerance checkpoints. So far, it is unclear how and when such autoreactive B cells emerge. Light chain (LC) rearrangement and mutation rates can be informative with regard to selection steps during B-cell development. Therefore, we studied LC characteristics of ACPA-expressing B cells and secreted ACPA with the aim to better understand the development of this disease-specific, autoreactive B-cell response. Paired ACPA-IgG and ACPA-depleted IgG were isolated from serum (n = 87) and synovial fluid (SF, n = 21) of patients with established RA. We determined the LC composition for each fraction by ELISA using kappa(Igκ)- and lambda(Igλ) LC-specific antibodies. Cellular LC expression was determined using flow cytometry. In addition, we used a B-cell receptor (BCR)-specific PCR to obtain LC variable region sequences of citrullinated antigen- and tetanus toxoid (TT)-binding B cells. In serum, we observed an increased frequency of lambda LC in ACPA-IgG (1.64:1) compared to control IgG (2.03:1) and to the κ/λ ratio reported for healthy individuals (2:1). A similar trend towards higher frequencies of lambda LCs was observed for ACPA-IgG in SF (1.84:1). Additionally, the percentage of Igλ-expressing B cells was higher for citrullinated antigen-binding B cells (51%) compared to TT-specific (43%) and total CD19(+)CD20(+) B cells (36%). Moreover, an increased Igλ percentage was observed in BCR-sequences derived from ACPA-expressing (49%) compared to TT-specific B cells (34%). Taken together, we report an enhanced frequency of lambda LCs in the secreted ACPA-IgG repertoire and, on the cellular level, in BCR sequences of ACPA-expressing B cells compared to control. This skewing in the autoreactive B-cell repertoire could reflect a process of active selection. Public Library of Science 2021-03-30 /pmc/articles/PMC8009422/ /pubmed/33784344 http://dx.doi.org/10.1371/journal.pone.0247847 Text en © 2021 Slot et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Slot, Linda M.
Vergroesen, Rochelle D.
Kerkman, Priscilla F.
Staudinger, Ellen
Reijm, Sanne
van Dooren, Hugo J.
van der Voort, Ellen I. H.
Huizinga, Tom W. J.
Toes, René E. M.
Scherer, Hans U.
Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis
title Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis
title_full Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis
title_fullStr Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis
title_full_unstemmed Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis
title_short Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis
title_sort light chain skewing in autoantibodies and b-cell receptors of the citrullinated antigen-binding b-cell response in rheumatoid arthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009422/
https://www.ncbi.nlm.nih.gov/pubmed/33784344
http://dx.doi.org/10.1371/journal.pone.0247847
work_keys_str_mv AT slotlindam lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis
AT vergroesenrochelled lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis
AT kerkmanpriscillaf lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis
AT staudingerellen lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis
AT reijmsanne lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis
AT vandoorenhugoj lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis
AT vandervoortellenih lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis
AT huizingatomwj lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis
AT toesreneem lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis
AT schererhansu lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis